Restricted heterochromatin formation links NFATc2 repressor activity with growth promotion in pancreatic cancer

Sandra Baumgart, Elisabeth Glesel, Garima Singh, Naiming Chen, Kristina Reutlinger, Jinsan Zhang, Daniel D Billadeau, Martin E Fernandez-Zapico, Thomas M. Gress, Shiv K. Singh, Volker Ellenrieder

Research output: Contribution to journalArticle

44 Citations (Scopus)

Abstract

Background & Aims: Transcriptional silencing of the p15 INK4b tumor suppressor pathway overcomes cellular protection against unrestrained proliferation in cancer. Here we show a novel pathway involving the oncogenic transcription factor nuclear factor of activated T cells (NFAT) c2 targeting a p15 INK4b-mediated failsafe mechanism to promote pancreatic cancer tumor growth. Methods: Immunohistochemistry, real-time polymerase chain reaction, immunoblotting, and immunofluorescence microscopy were used for expression studies. Cancer growth was assessed in vitro by [ 3H] thymidine incorporation, colony formation assays, and in vivo using xenograft tumor models. Protein-protein interactions, promoter regulation, and local histone modifications were analyzed by immunoprecipitation, DNA pull-down, reporter, and chromatin immunoprecipitation assays. Results: Our study uncovered induction of NFATc2 in late-stage pancreatic intraepithelial neoplasia lesions with increased expression in tumor cell nuclei of advanced cancers. In the nucleus, NFATc2 targets the p15 INK4b promoter for inducible heterochromatin formation and silencing. NFATc2 binding to its cognate promoter site induces stepwise recruitment of the histone methyltransferase Suv39H1, causes local H3K9 trimethylation, and allows docking of heterochromatin protein HP1γ to the repressor complex. Conversely, inactivation of NFATc2 disrupts this repressor complex assembly and local heterochromatin formation, resulting in restoration of p15 INK4b expression and inhibition of pancreatic cancer growth in vitro and in vivo. Conclusions: Here we describe a novel mechanism for NFATc2-mediated gene regulation and identify a functional link among its repressor activity, the silencing of the suppressor pathway p15 INK4b, and its pancreatic cancer growth regulatory functions. Thus, we provide evidence that inactivation of oncogenic NFATc2 might be an attractive strategy in treatment of pancreatic cancer.

Original languageEnglish (US)
JournalGastroenterology
Volume142
Issue number2
DOIs
StatePublished - Feb 2012

Fingerprint

Heterochromatin
Pancreatic Neoplasms
Growth
Neoplasms
Histone Code
NFATC Transcription Factors
Proteins
Chromatin Immunoprecipitation
Cell Nucleus
Fluorescence Microscopy
Immunoprecipitation
Immunoblotting
Heterografts
Thymidine
Real-Time Polymerase Chain Reaction
Transcription Factors
Immunohistochemistry
DNA

Keywords

  • Gene Silencing
  • Heterochromatin
  • NFAT
  • p15
  • Pancreatic Cancer

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Baumgart, S., Glesel, E., Singh, G., Chen, N., Reutlinger, K., Zhang, J., ... Ellenrieder, V. (2012). Restricted heterochromatin formation links NFATc2 repressor activity with growth promotion in pancreatic cancer. Gastroenterology, 142(2). https://doi.org/10.1053/j.gastro.2011.11.001

Restricted heterochromatin formation links NFATc2 repressor activity with growth promotion in pancreatic cancer. / Baumgart, Sandra; Glesel, Elisabeth; Singh, Garima; Chen, Naiming; Reutlinger, Kristina; Zhang, Jinsan; Billadeau, Daniel D; Fernandez-Zapico, Martin E; Gress, Thomas M.; Singh, Shiv K.; Ellenrieder, Volker.

In: Gastroenterology, Vol. 142, No. 2, 02.2012.

Research output: Contribution to journalArticle

Baumgart, Sandra ; Glesel, Elisabeth ; Singh, Garima ; Chen, Naiming ; Reutlinger, Kristina ; Zhang, Jinsan ; Billadeau, Daniel D ; Fernandez-Zapico, Martin E ; Gress, Thomas M. ; Singh, Shiv K. ; Ellenrieder, Volker. / Restricted heterochromatin formation links NFATc2 repressor activity with growth promotion in pancreatic cancer. In: Gastroenterology. 2012 ; Vol. 142, No. 2.
@article{d4ead5109a754dc5a83578566bacb1aa,
title = "Restricted heterochromatin formation links NFATc2 repressor activity with growth promotion in pancreatic cancer",
abstract = "Background & Aims: Transcriptional silencing of the p15 INK4b tumor suppressor pathway overcomes cellular protection against unrestrained proliferation in cancer. Here we show a novel pathway involving the oncogenic transcription factor nuclear factor of activated T cells (NFAT) c2 targeting a p15 INK4b-mediated failsafe mechanism to promote pancreatic cancer tumor growth. Methods: Immunohistochemistry, real-time polymerase chain reaction, immunoblotting, and immunofluorescence microscopy were used for expression studies. Cancer growth was assessed in vitro by [ 3H] thymidine incorporation, colony formation assays, and in vivo using xenograft tumor models. Protein-protein interactions, promoter regulation, and local histone modifications were analyzed by immunoprecipitation, DNA pull-down, reporter, and chromatin immunoprecipitation assays. Results: Our study uncovered induction of NFATc2 in late-stage pancreatic intraepithelial neoplasia lesions with increased expression in tumor cell nuclei of advanced cancers. In the nucleus, NFATc2 targets the p15 INK4b promoter for inducible heterochromatin formation and silencing. NFATc2 binding to its cognate promoter site induces stepwise recruitment of the histone methyltransferase Suv39H1, causes local H3K9 trimethylation, and allows docking of heterochromatin protein HP1γ to the repressor complex. Conversely, inactivation of NFATc2 disrupts this repressor complex assembly and local heterochromatin formation, resulting in restoration of p15 INK4b expression and inhibition of pancreatic cancer growth in vitro and in vivo. Conclusions: Here we describe a novel mechanism for NFATc2-mediated gene regulation and identify a functional link among its repressor activity, the silencing of the suppressor pathway p15 INK4b, and its pancreatic cancer growth regulatory functions. Thus, we provide evidence that inactivation of oncogenic NFATc2 might be an attractive strategy in treatment of pancreatic cancer.",
keywords = "Gene Silencing, Heterochromatin, NFAT, p15, Pancreatic Cancer",
author = "Sandra Baumgart and Elisabeth Glesel and Garima Singh and Naiming Chen and Kristina Reutlinger and Jinsan Zhang and Billadeau, {Daniel D} and Fernandez-Zapico, {Martin E} and Gress, {Thomas M.} and Singh, {Shiv K.} and Volker Ellenrieder",
year = "2012",
month = "2",
doi = "10.1053/j.gastro.2011.11.001",
language = "English (US)",
volume = "142",
journal = "Gastroenterology",
issn = "0016-5085",
publisher = "W.B. Saunders Ltd",
number = "2",

}

TY - JOUR

T1 - Restricted heterochromatin formation links NFATc2 repressor activity with growth promotion in pancreatic cancer

AU - Baumgart, Sandra

AU - Glesel, Elisabeth

AU - Singh, Garima

AU - Chen, Naiming

AU - Reutlinger, Kristina

AU - Zhang, Jinsan

AU - Billadeau, Daniel D

AU - Fernandez-Zapico, Martin E

AU - Gress, Thomas M.

AU - Singh, Shiv K.

AU - Ellenrieder, Volker

PY - 2012/2

Y1 - 2012/2

N2 - Background & Aims: Transcriptional silencing of the p15 INK4b tumor suppressor pathway overcomes cellular protection against unrestrained proliferation in cancer. Here we show a novel pathway involving the oncogenic transcription factor nuclear factor of activated T cells (NFAT) c2 targeting a p15 INK4b-mediated failsafe mechanism to promote pancreatic cancer tumor growth. Methods: Immunohistochemistry, real-time polymerase chain reaction, immunoblotting, and immunofluorescence microscopy were used for expression studies. Cancer growth was assessed in vitro by [ 3H] thymidine incorporation, colony formation assays, and in vivo using xenograft tumor models. Protein-protein interactions, promoter regulation, and local histone modifications were analyzed by immunoprecipitation, DNA pull-down, reporter, and chromatin immunoprecipitation assays. Results: Our study uncovered induction of NFATc2 in late-stage pancreatic intraepithelial neoplasia lesions with increased expression in tumor cell nuclei of advanced cancers. In the nucleus, NFATc2 targets the p15 INK4b promoter for inducible heterochromatin formation and silencing. NFATc2 binding to its cognate promoter site induces stepwise recruitment of the histone methyltransferase Suv39H1, causes local H3K9 trimethylation, and allows docking of heterochromatin protein HP1γ to the repressor complex. Conversely, inactivation of NFATc2 disrupts this repressor complex assembly and local heterochromatin formation, resulting in restoration of p15 INK4b expression and inhibition of pancreatic cancer growth in vitro and in vivo. Conclusions: Here we describe a novel mechanism for NFATc2-mediated gene regulation and identify a functional link among its repressor activity, the silencing of the suppressor pathway p15 INK4b, and its pancreatic cancer growth regulatory functions. Thus, we provide evidence that inactivation of oncogenic NFATc2 might be an attractive strategy in treatment of pancreatic cancer.

AB - Background & Aims: Transcriptional silencing of the p15 INK4b tumor suppressor pathway overcomes cellular protection against unrestrained proliferation in cancer. Here we show a novel pathway involving the oncogenic transcription factor nuclear factor of activated T cells (NFAT) c2 targeting a p15 INK4b-mediated failsafe mechanism to promote pancreatic cancer tumor growth. Methods: Immunohistochemistry, real-time polymerase chain reaction, immunoblotting, and immunofluorescence microscopy were used for expression studies. Cancer growth was assessed in vitro by [ 3H] thymidine incorporation, colony formation assays, and in vivo using xenograft tumor models. Protein-protein interactions, promoter regulation, and local histone modifications were analyzed by immunoprecipitation, DNA pull-down, reporter, and chromatin immunoprecipitation assays. Results: Our study uncovered induction of NFATc2 in late-stage pancreatic intraepithelial neoplasia lesions with increased expression in tumor cell nuclei of advanced cancers. In the nucleus, NFATc2 targets the p15 INK4b promoter for inducible heterochromatin formation and silencing. NFATc2 binding to its cognate promoter site induces stepwise recruitment of the histone methyltransferase Suv39H1, causes local H3K9 trimethylation, and allows docking of heterochromatin protein HP1γ to the repressor complex. Conversely, inactivation of NFATc2 disrupts this repressor complex assembly and local heterochromatin formation, resulting in restoration of p15 INK4b expression and inhibition of pancreatic cancer growth in vitro and in vivo. Conclusions: Here we describe a novel mechanism for NFATc2-mediated gene regulation and identify a functional link among its repressor activity, the silencing of the suppressor pathway p15 INK4b, and its pancreatic cancer growth regulatory functions. Thus, we provide evidence that inactivation of oncogenic NFATc2 might be an attractive strategy in treatment of pancreatic cancer.

KW - Gene Silencing

KW - Heterochromatin

KW - NFAT

KW - p15

KW - Pancreatic Cancer

UR - http://www.scopus.com/inward/record.url?scp=84856233403&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84856233403&partnerID=8YFLogxK

U2 - 10.1053/j.gastro.2011.11.001

DO - 10.1053/j.gastro.2011.11.001

M3 - Article

C2 - 22079596

AN - SCOPUS:84856233403

VL - 142

JO - Gastroenterology

JF - Gastroenterology

SN - 0016-5085

IS - 2

ER -